Results 71 to 80 of about 418,673 (161)
Effect of tirzepatide vs insulin (insulin degludec and insulin glargine) on body weight.
, 2023 Effect of tirzepatide vs insulin (insulin degludec and insulin glargine) on body weight.
Bin Yu (14464) +8 more
core +1 more source
Therapeutic Advances in Endocrinology and Metabolism, 2012 The three currently marketed long-acting insulin analogs, glargine, detemir and insulin lispro protamine suspension (ILPS), represent the most significant advances in basal insulin supplementation since the 1940s and 1950s and the introduction of the ...
Dario Giugliano, Katherine Esposito
doaj +1 more source
Insulin detemir versus insulin glargine for type 2 diabetes mellitus
, 2011 Chronically elevated blood glucose levels are associated with significant morbidity and mortality. Many diabetes patients will eventually require insulin treatment to maintain good glycaemic control.
Hoekstra, Joost B. +4 more
core +1 more source
Indian Journal of Endocrinology and Metabolism, 2014 Aim: To determine the safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) therapy in the Indian patients with type 2 diabetes previously on basal or basal-bolus insulin therapies.
Arpandev Bhattacharyya +3 more
doaj +1 more source
Recombinant glargine insulin production process using Escherichia coli
, 2016 Glargine insulin is a long-acting insulin analog that helps blood glucose maintenance in patients with diabetes. We constructed the pPT-GI vector to express prepeptide glargine insulin when transformed into Escherichia coli JM109. The transformed E. coli
C K Kim +7 more
core +1 more source
Сахарный диабет, 2010 Results of 31 controlled randomized studies of insulin glargine given to patients with diabetes mellitus are reviewed to evaluate the frequency of malignantneoplasms.
Marina Vladimirovna Shestakova +1 more
doaj +1 more source
Drug review - insulin glargine: a long acting insulin analog
, 2005 The main goal of treatment of diabetes mellitus (DM) is to maintain long term near normoglycemia. Insulin therapy plays a pivotal role in the management of DM.
P. N. Chakkarwar, N. A. Manjreka
core +3 more sources
ClinicoEconomics and Outcomes Research, 2020 Asrul Akmal Shafie,1 Chin Hui Ng2 1Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Penang, Malaysia; 2Pharmacy Department, Hospital Raja Permaisuri Bainun, Ipoh 30450, Perak, MalaysiaCorrespondence: Asrul Akmal ...
Shafie AA, Ng CH
doaj
Study of the aggregation of insulin glargine by light scattering
, 2006 Insulin glargine (Lantus1, Aventis Pharma, Deutschland, GmbH) is a new long-acting human insulin analog. Structural modification of the insulin molecule at two sites alters its pH, causing insulin glargine to precipitate in the neutral environment of ...
R Coppolino, S Coppolino, V Villari
core +1 more source
United States experience of insulin Degludec alone or in combination for type 1 and type 2 diabetes
Drug Design, Development and Therapy, 2017 Marc Rendell1,2 1The Rose Salter Medical Research Foundation, 2The Association of Diabetes Investigators, Newport Coast, CA, USA Abstract: Insulin degludec has been the product of a sophisticated and systematic biochemical engineering program which ...
Rendell M
doaj